‘Too big to care’: Sweeping lawsuit accuses Teva of colluding with other generic makers to keep prices high
Teva has been accused of being a ringleader in a massive price-fixing conspiracy alongside 19 other generic drugmakers in the US, causing price spikes of as much as 1000% from 2013 to 2015, according to an antitrust lawsuit filed by 44 states.
The lawsuit, which also names 15 individuals, is the second to be filed in an “ongoing, expanding investigation” on the generic drug industry — “the largest private sector corporate cartel in history” according to Connecticut attorney general William Tong. Under his predecessor, the state teamed up with a fewer number of states in 2016 to sue some of the same companies over two drugs. Today, the list has grown to 114.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.